AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Keynotes Highlight Basic and Clinical Research
Cancers are driven by unique genetic alterations, so what if we targeted these alterations to treat the cancer? It seems...
Cancers are driven by unique genetic alterations, so what if we targeted these alterations to treat the cancer? It seems...
For our readers who enjoy learning about the newest tools and strategies in cancer research, the second installment of...
Neuroblastoma, a rare cancer that occurs primarily in children, is a scientific paradox, said pediatric oncologist John M. Maris,...
The AACR Annual Meeting 2023, held April 14-19, commemorated several milestones, including the 25th anniversary of the approval of...
As the temperatures start to drop and the leaves begin to change color, enjoy the latest selection of studies...
FDA approvals issued in third quarter 2023 included a new treatment for prostate cancer harboring BRCA mutations, two new...
Based on estimates from the National Cancer Institute, in 2023, more than 110,000 cases of gynecologic cancers are expected...
As you say farewell to summer, say hello to the latest installment of Editors’ Picks selected by the editors...
In the span of a decade, the idea that tumor-derived molecules circulating in the bloodstream and other body fluids...
Bacteria account for over 75% of the Earth’s population. And while we often think of these microbes as something...